Member Exclusive News

The week in industry: AstraZeneca and BenevolentAI collaborate to accelerate drug discovery

This week: The US FDA extends the use of BENLYSTA® to include children with lupus aged five and over, Abbvie (IL, USA) continues to gain worldwide approval of SKRIZI™ in Europe and Takeda (Tokyo, Japan) open new research facility in San Diego.

Go to the profile of RxNet
May 02, 2019

Please sign in or register for FREE

No comments yet.